About Pricing FAQs Blog

Loading clinical trials...

Your health journey, clearly organized.

Find Clinical Trials →

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

COMPLETEDPhase 1

Drug-Drug Interaction Study of HBI-3000 and Paroxetine in Healthy Adult Male and Female Subjects

Open-Label, Two-Period Phase 1 Study in Healthy Subjects to Evaluate the Potential Effect of Multiple Doses of Paroxetine on the Pharmacokinetics and Safety of HBI-3000

NCT04650542•HUYABIO International, LLC.

View on ClinicalTrials.gov

AI summary by Clareo Health

Generating AI summary...

Conditions

Drug-drug Interaction

Interventions

HBI-3000

Paroxetine

Locations

2

United States

Locations (2)

Spaulding Clinical

West Bend, Wisconsin, United States

Nucleus Network Pty Ltd.

Melbourne, Victoria, Australia

Key Dates

Start Date

February 21, 2021

Primary Completion Date

August 13, 2021

Completion Date

August 13, 2021

Last Updated

July 15, 2022

Related Studies

Pharmaco-proteomic Platform to Evaluate Drug Interactions in Liver Transplant Patients

NCT06682325

Drug-drug InteractionLiver Transplantation

COMPLETEDPhase 1

A Study to Assess the Effect of Ceftobiprole on the PK of Pitavastatin and on Plasma Levels of Coproporphyrin

NCT06808646

Drug-drug Interaction Study

Not Yet RecruitingPhase 1

Effect of Dexamethasone on CYP Enzyme Activity in Healthy Male Subjects

NCT07426042

Drug-Drug Interactions

Not Yet RecruitingPhase 4

Drug-drug Interaction Study of Rifampin and Anaprazole Sodium

NCT07330531

Drug-drug Interaction Study

COMPLETEDPhase 1

Drug-Drug Interaction Between R1_PBK_M2301 and R2_PBK_M2301 in Healthy Adults

NCT07017335

Drug-Drug Interaction Healthy Volunteers

COMPLETEDPhase 4

Dihydroartemisinin-Piperaquine in the Context of Antiretroviral Therapy

NCT04487145

Drug-Drug InteractionHIV Infection

View all related studies

Sponsors

Lead Sponsor

HUYABIO International, LLC.

Detailed Description

Full Eligibility Criteria

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: July 15, 2022Data synced to Clareo: April 28, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions